GT Biopharma Inc

GT Biopharma Inc

GTBP · NASDAQ · Healthcare / Biotechnology

3.72USD-0.12 (-3.12%)

Price History

Full chart

Market Stats

Previous Close3.84
Open3.85
Day Range3.60 – 4.11
52-Week Range4.91 – 34.25
Volume66.92K
Market Cap12.32M
P/E (TTM)0.05
Forward P/E17.33
EPS130.25
Dividend Yield0.00%
Beta0.91
50-Day Avg7.63
200-Day Avg11.33

About

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 trials that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550, that is in phase 1 dose escalation basket trial that targets B7-H3 on the surface of advanced solid tumors;and GTB-7550, a pre-clinical stage product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Michael Martin Breen L.L.B.
  • Employees1
  • Headquarters315 Montgomery Street, San Francisco, CA, United States, 94104, USA
  • Websitehttps://www.gtbiopharma.com

Leadership

  • Mr. Michael Martin Breen L.L.B.President, CEO & Executive Chairman · b. 1963
  • Mr. Alan Louis Urban CPACFO & Secretary · b. 1968

Financials

Income Statement

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.00M2.30M3.20M5.10M4.80M2.70M2.80M3.00M3.50M5.10M4.80M5.10M5.10M7.17M3.54M2.97M2.05M2.74M2.36M2.50M5.78M6.05M1.14M48.00K11.00K26.00K342.00K368.00K61.00K27.00K027.00K00000000
Growth (%)--23.33%+39.13%+59.38%-5.88%-43.75%+3.70%+7.14%+16.67%+45.71%-5.88%+6.25%0.00%+40.49%-50.59%-16.16%-30.93%+33.66%-13.72%+5.63%+131.32%+4.73%-81.10%-95.80%-77.08%+136.36%+1215.38%+7.60%-83.42%-55.74%-100.00%--100.00%-------
Cost of Revenue1.10M500.00K1.20M2.10M1.90M1.00M1.20M1.20M1.50M1.60M1.60M2.00M2.60M5.05M2.62M2.43M1.14M1.50M1.22M1.34M3.08M3.26M909.00K50.00K65.00K48.00K94.00K226.00K57.00K2.00K1.00K2.00K7.00K4.00K------
Gross Profit1.90M1.80M2.00M3.00M2.90M1.70M1.60M1.80M2.00M3.50M3.20M3.10M2.50M2.11M924.00K538.00K910.00K1.24M1.15M1.15M2.69M2.79M234.00K-2.00K-54.00K-22.00K248.00K142.00K4.00K25.00K-1.00K-2.00K-7.00K-4.00K------
Gross Margin63.33%78.26%62.50%58.82%60.42%62.96%57.14%60.00%57.14%68.63%66.67%60.78%49.02%29.50%26.10%18.13%44.39%45.40%48.56%46.14%46.61%46.09%20.47%-4.17%-490.91%-84.62%72.51%38.59%6.56%92.59%--7.41%--------
Operating Expense2.50M1.60M2.10M2.50M2.40M2.20M2.10M3.50M4.00M9.00M9.10M8.10M9.60M6.52M5.65M3.99M1.72M2.02M2.87M4.34M5.36M3.90M1.45M1.15M2.44M3.91M3.76M935.00K2.40M8.95M9.37M135.57M250.06M11.45M------
Operating Income-600.00K200.00K-100.00K500.00K500.00K-500.00K-500.00K-1.70M-2.00M-5.50M-5.90M-5.00M-7.10M-4.41M-4.73M-3.45M-811.00K-773.00K-1.72M-3.19M-2.67M-1.12M-1.21M-1.16M-2.50M-3.93M-3.51M-793.00K-2.40M-8.93M-9.37M-135.57M-250.07M-11.46M-6.76M-57.52M-21.26M-13.58M-14.36M-12.42M
Operating Margin-20.00%8.70%-3.13%9.80%10.42%-18.52%-17.86%-56.67%-57.14%-107.84%-122.92%-98.04%-139.22%-61.55%-133.50%-116.34%-39.56%-28.21%-72.72%-127.71%-46.23%-18.45%-105.95%-2408.33%-22700.00%-15107.69%-1027.49%-215.49%-3927.87%-33062.96%--502111.11%--------
EBITDA-600.00K200.00K-100.00K500.00K500.00K-500.00K-500.00K-1.60M-5.00M-4.10M-4.50M-3.80M-5.50M-3.57M-4.28M-3.04M-529.00K-596.00K-329.00K-1.53M-2.37M-223.00K-3.02M-1.05M-2.45M-3.12M-3.51M-791.00K-2.37M-8.93M-9.37M-135.57M-250.06M-36.52M-24.97M-57.48M-20.96M5.98M-13.16M-28.23M
EBITDA Margin-20.00%8.70%-3.13%9.80%10.42%-18.52%-17.86%-53.33%-142.86%-80.39%-93.75%-74.51%-107.84%-49.85%-120.99%-102.46%-25.80%-21.75%-13.92%-61.47%-41.01%-3.69%-264.30%-2197.92%-22281.82%-12003.85%-1026.61%-214.95%-3891.80%-33055.56%--502103.70%--------
Net Income-400.00K300.00K100.00K700.00K900.00K-200.00K-300.00K-1.50M-5.60M-8.90M-6.00M-5.20M-7.10M-4.50M-4.68M-3.50M-822.00K-791.00K-2.70M-3.11M-4.94M471.00K-5.01M-2.25M-3.00M-3.70M-5.17M-501.00K-23.49M-21.46M9.77M-144.17M-259.19M-38.65M-28.30M-58.01M-20.88M-7.60M-13.16M-28.35M
Net Income Margin-13.33%13.04%3.13%13.73%18.75%-7.41%-10.71%-50.00%-160.00%-174.51%-125.00%-101.96%-139.22%-62.74%-132.32%-117.76%-40.10%-28.87%-114.13%-124.51%-85.53%7.79%-437.97%-4679.17%-27227.27%-14230.77%-1511.99%-136.14%-38506.56%-79485.19%--533970.37%--------
R&D--------1.70M4.30M4.90M4.30M4.40M2.40M1.91M762.00K463.00K369.00K278.00K499.00K708.00K1.04M44.00K44.00K179.00K17.00K--1.00M1.00M975.00K1.07M9.07M1.67M485.00K9.59M8.81M6.47M5.80M3.47M
R&D as % of Total Revenue--------48.57%84.31%102.08%84.31%86.27%33.51%53.95%25.67%22.59%13.47%11.76%19.98%12.26%17.14%3.85%91.67%1627.27%65.38%--1639.34%3703.70%-3955.56%--------
Interest Expense000000000200.00K100.00K0300.00K090.00K14.00K18.00K14.00K101.00K26.00K2.16M1.01M01.14M513.00K556.00K005.15M17.04M6.55M8.60M9.12M2.13M3.32M718.00K8.00K213.00K0127.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.92%2.08%0.00%5.88%0.00%2.54%0.47%0.88%0.51%4.27%1.04%37.36%16.76%0.00%2366.67%4663.64%2138.46%0.00%0.00%8436.07%63107.41%-31859.26%--------

Balance Sheet

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.30M3.30M3.50M4.40M5.00M4.80M4.90M3.10M11.20M9.90M8.00M12.60M11.20M5.18M5.63M1.72M1.99M1.96M8.48M7.81M8.00M4.86M590.00K1.38M185.00K129.00K226.00K147.00K888.00K54.00K25.00K254.37M25.40M396.00K5.66M32.17M16.74M14.11M4.23M8.11M
Total Liabilities500.00K200.00K300.00K500.00K200.00K200.00K600.00K300.00K4.50M5.60M3.50M5.80M4.00M2.50M1.55M1.19M767.00K1.09M2.68M4.27M7.80M3.23M4.27M7.11M5.65M5.23M6.56M6.48M30.46M50.62M18.95M2.68M14.03M19.71M35.09M10.26M5.00M6.63M5.90M2.32M
Total Equity2.80M3.10M3.20M3.90M4.80M4.60M4.30M2.80M6.70M4.30M4.50M6.80M7.20M2.69M4.07M533.00K1.22M870.00K5.80M2.93M-575.00K763.00K-3.68M-5.72M-5.47M-5.10M-6.34M-6.33M-29.41M-50.40M-18.75M251.86M11.54M-19.14M-29.26M21.91M11.73M7.48M-1.67M5.79M
Cash2.40M2.40M2.60M3.60M4.70M300.00K300.00K800.00K900.00K700.00K400.00K1.30M2.60M789.00K2.06M221.00K424.00K372.00K4.69M614.00K1.21M1.14M22.00K1.29M54.00K92.00K123.00K43.00K855.00K47.00K19.00K576.00K60.00K28.00K5.30M8.97M5.67M1.08M3.95M6.81M
Total Debt--------1.10M3.20M1.30M3.10M2.40M969.00K409.00K254.00K160.00K160.00K1.36M3.06M3.18M-2.15M2.37M2.16M2.06M1.88M1.71M3.36M9.75M12.41M31.00K10.80M13.36M26.33M31.00K174.00K58.00K--
Net Debt-2.40M-2.40M-2.60M-3.60M-4.70M-300.00K-300.00K-800.00K200.00K2.50M900.00K1.80M-200.00K180.00K-1.65M33.00K-264.00K-212.00K-3.33M2.45M1.98M-1.14M2.13M1.08M2.11M1.97M1.76M1.67M2.50M9.70M12.39M-545.00K10.74M13.33M21.04M-8.94M-5.50M-1.02M-3.95M-6.81M

Cash Flow

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-400.00K50.00K100.00K700.00K900.00K-200.00K-500.00K-1.60M400.00K-5.30M-4.30M-4.80M-5.20M-2.48M-3.89M-1.43M-1.01M-229.00K-1.04M-2.09M-671.00K-270.00K-169.00K-937.00K-1.53M-963.00K-987.00K-442.00K-1.75M-4.66M-1.93M-5.43M-10.68M-3.66M-7.26M-15.61M-15.22M-8.85M-12.90M-12.91M
Investing Cash Flow--370.00K----100.00K500.00K2.00M-400.00K-400.00K-100.00K-200.00K2.15M-303.00K-156.00K-180.00K-98.00K-309.00K-6.07M-108.00K2.76M-------6.00K-1.00K-1.00K-4.00K-36.00K200.00K-23.04M-23.04M12.14M-2.01M12.89M-
Financing Cash Flow---------4.60M4.40M5.90M6.80M-1.48M5.47M-212.00K1.41M247.00K5.69M4.09M1.37M-2.56M-2.21M296.00K1.00M930.00K425.00K2.58M3.85M1.90M5.99M10.20M3.43M12.53M42.32M-224.00K6.27M2.98M15.78M
Capital Expenditure050.00K0000100.00K100.00K0100.00K100.00K100.00K100.00K381.00K160.00K11.00K6.00K13.00K47.00K205.00K108.00K97.00K00002.00K06.00K1.00K4.00K4.00K36.00K0000000
Free Cash Flow-400.00K-100.00K700.00K900.00K-200.00K-600.00K-1.70M400.00K-5.40M-4.40M-4.90M-5.30M-2.86M-4.05M-1.44M-1.01M-242.00K-3.34M-2.30M-779.00K-367.00K-169.00K-937.00K-1.53M-963.00K-989.00K-442.00K-1.75M-4.66M-1.93M-5.43M-10.71M-3.66M-7.26M-15.61M-15.22M-8.85M-12.90M-12.91M
Dividends Paid--------------------------------------0229.00K
FCF to OCF100.00%-100.00%100.00%100.00%100.00%120.00%106.25%100.00%101.89%102.33%102.08%101.92%115.38%104.12%100.77%100.60%105.68%320.44%109.79%116.10%135.93%100.00%100.00%100.00%100.00%100.20%100.00%100.34%100.02%100.00%100.07%100.34%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF--------------------------------------0.00%-1.77%

Earnings

Report DateMar 31, 1998Jun 30, 1998Sep 30, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Aug 6, 2003Dec 3, 2003May 2, 2004Aug 6, 2004Nov 15, 2004Mar 2, 2005May 2, 2005Aug 15, 2005Nov 15, 2005Mar 1, 2006May 1, 2006Aug 15, 2006Nov 14, 2006Apr 30, 2007Aug 14, 2007Nov 13, 2007Feb 27, 2008Apr 28, 2008Aug 19, 2008Nov 18, 2008Feb 25, 2009May 4, 2009Aug 18, 2009Nov 17, 2009Mar 3, 2010May 3, 2010Aug 17, 2010Nov 16, 2010Mar 2, 2011May 16, 2011Aug 22, 2011Nov 21, 2011Feb 29, 2012May 21, 2012Aug 20, 2012Oct 24, 2012Feb 27, 2013Apr 29, 2013Aug 13, 2013Nov 12, 2013Feb 26, 2014Apr 28, 2014Aug 19, 2014Dec 17, 2014Mar 31, 2015May 4, 2015Aug 18, 2015Nov 17, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Nov 14, 2017Feb 28, 2018May 15, 2018Aug 14, 2018Nov 15, 2018Mar 29, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 27, 2020May 15, 2020Aug 14, 2020Nov 13, 2020Dec 31, 2020May 17, 2021Aug 23, 2021Nov 10, 2021Mar 28, 2022May 16, 2022Aug 15, 2022Oct 31, 2022Mar 30, 2023May 15, 2023Aug 7, 2023Nov 1, 2023Mar 26, 2024May 15, 2024Aug 14, 2024Nov 14, 2024Feb 21, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Dec 31, 2025May 15, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate------------------------12750.00---------------------0.00---------------------------------------0.04-9.90-7.65-7.05-6.30-0.31-5.40-3.30-0.17-4.35-3.60-3.30-2.70-2.70-2.70-2.70-1.55-0.64-0.68-0.38-5.50-0.08-0.08-2.50
EPS Actual-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-1000000.00-777507.26-630853.02-1000000.00-569550.09-1000000.00-212326.75-854454.55-1000000.00-75813.93-1000000.00-218681.66-12750.00-286615.59-1000000.00-620442.22-519608.72-579650.97-664879.91925878.52-100129.33382497.99-893163.30-1000000.00-650686.61-359225.39-233496.07-289829.04-218800.52-1000000.00-1000000.00148881.15-194465.86-231512.24-12750.00-272.318.08-216452.27-163.04-545.66-264.18-58149.7524941.54-20424.86-21292.59-23628.76-24763.48-17487.96-9118.63-40156.03-1000000.00837452.78-107865.03252.0018.00-39.65-29.41-448.21-87.40-138.55-8.15-0.12-0.20-0.18-4.70-0.08-0.09-0.05-0.51-0.02-0.02-0.12-0.04-3.39-54.90-3.92-5.69-15.76-0.17-2.86-6.61-0.18-2.85-2.54-2.13-2.19-1.64-2.17-1.53-1.66-0.76-0.55-0.83-121.00-0.11-0.12-
Surprise-----------------------0.00%-------------------------------------------------------------8375.00%-454.55%48.76%19.29%-150.16%45.16%47.04%-100.30%-5.88%34.48%29.44%35.45%18.89%39.26%19.74%43.33%-7.10%-18.75%19.12%-118.42%-2100.00%-37.50%-50.00%-
Timing----------------------------------------------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-------After-hoursAfter-hours---------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap12.32M
Enterprise Value7.85M
Trailing P/E0.05
Forward P/E17.33
PEG Ratio1.05
Price / Sales204.96
Price / Book3.59
EPS130.25
Book Value2.00
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-6.76M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-113.52%
Return on Assets-158.16%
Shares Outstanding1.80M
Shares Float1.70M
Beta0.91
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 75.00
  • Buy
    1

Ownership Breakdown

Institutions
4.66%
Insiders
5.71%
Retail / Other
89.63%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    451.88K1.77%
  • Geode Capital Management, LLC
    294.46K1.15%
  • Vanguard Fiduciary Trust Co
    225.94K0.88%
  • Everhart Financial Group, Inc.
    100.00K0.39%
  • SRS Capital Advisors Inc
    93.63K0.37%
  • Opal Wealth Advisors, LLC
    81.81K0.32%
  • Seacrest Wealth Management, LLC
    50.10K0.20%
  • KITCHING PARTNERS LLC
    50.00K0.20%
  • UBS Group AG
    45.97K0.18%
  • Integrated Wealth Concepts LLC
    40.01K0.16%
  • TWO SIGMA SECURITIES, LLC
    31.80K0.12%
  • LPL Financial Corp
    30.38K0.12%
  • Invst LLC
    23.40K0.09%
  • Advisor Group Holdings, Inc.
    21.00K0.08%
  • BlueCreek Investment Partners, LLC
    20.77K0.08%
  • HPM Partners LLC
    20.02K0.08%
  • CI Private Wealth LLC
    20.00K0.08%
  • Private Wealth Management Group LLC
    20.00K0.08%

Top Fund Holders

  • Fidelity Extended Market Index
    168.03K0.66%
  • Fidelity Series Total Market Index
    61.94K0.24%

Stock Splits

  • Sep 8, 20261:25
  • Feb 5, 20241:30
  • Feb 11, 20211:17